UPDATE: FDA Has Determined There Is No Clinical Need To Compound Vasopressin And As A Result, It Will Be Unlawful For Compounding Facilities To Sell Vasopressin Products Unless They Manufacture Them Using An FDA-Approved Product
Benzinga Newsdesk